Specifically, V9302 has been shown to promote cancer cell autophagy, further enhance anti-tumor immunity by regulating ROS accumulation, decrease the expression of the T-cell co-suppressor molecule B7H3, and promote the production of GZMB by CD8 T cells [109]. This evidence concerns the gene CD8A and cancer.